Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$292K Buy
100,000
+500
+0.5% +$1.49K 0.01% 775
2026
Q2
$312K Sell
99,500
-2,500
-2% -$7.82K 0.01% 734
2026
Q1
$298K Sell
102,000
-3,400
-3% -$9.7K 0.01% 702
2025
Q4
$260K Buy
105,400
+2,500
+2% +$5.95K 0.01% 753
2025
Q3
$229K Sell
102,900
-4,000
-4% -$9.15K 0.01% 785
2025
Q2
$258K Sell
106,900
-3,000
-3% -$7.3K 0.01% 708
2025
Q1
$256K Buy
109,900
+1,500
+1% +$3K 0.01% 696
2024
Q4
$201K Sell
108,400
-3,000
-3% -$6.64K 0.01% 811
2024
Q3
$272K Buy
111,400
+10,700
+11% +$24K 0.01% 687
2024
Q2
$206K Buy
100,700
+37,250
+59% +$84.8K 0.01% 758
2024
Q1
$157K Sell
63,450
-300
-0.5% -$781 0.01% 836
2023
Q4
$178K Sell
63,750
-1,000
-2% -$2.7K 0.01% 767
2023
Q3
$167K Sell
64,750
-1,200
-2% -$3.47K 0.01% 771
2023
Q2
$210K Buy
65,950
+1,800
+3% +$5.3K 0.01% 732
2023
Q1
$181K Buy
64,150
+3,700
+6% +$9.7K 0.01% 762
2022
Q4
$164K Sell
60,450
-1,750
-3% -$5.1K 0.01% 767
2022
Q3
$176K Buy
62,200
+700
+1% +$1.98K 0.01% 719
2022
Q2
$154K Buy
61,500
+4,150
+7% +$11.8K 0.01% 727
2022
Q1
$185K Buy
57,350
+5,450
+11% +$15.2K 0.01% 779
2021
Q4
$145K Buy
51,900
+20,150
+63% +$57.7K 0.01% 796
2021
Q3
$85K Hold
31,750
– – 0.01% 807
2021
Q2
$109K Buy
31,750
+400
+1% +$1.3K 0.01% 768
2021
Q1
$82K Buy
31,350
+11,300
+56% +$31.9K 0.01% 732
2020
Q4
$66K Buy
20,050
+2,300
+13% +$6.2K 0.01% 708
2020
Q3
$40K Buy
17,750
+100
+0.6% +$251 ﹤0.01% 675
2020
Q2
$46K Buy
+17,650
New +$41.6K ﹤0.01% 642

Other funds holding ABEV

Moors & Cabot's ABEV Position: Q3 2026 in Review

Moors & Cabot increased its Ambev (ABEV) stake by 0.5% in Q3 2026, buying an estimated $1.49K and bringing the position to 100,000 shares worth $292K. The position accounts for 0.01% of the portfolio, ranked #775.

Moors & Cabot first reported a position in ABEV in Q2 2020 and has held it in 26 quarters since. The position peaked at $312K in Q2 2026. 197 funds tracked by Wall St. Rank hold ABEV as of Q3 2026.

  • Moors & Cabot held 100,000 shares of Ambev worth $292K as of Q3 2026.
  • Moors & Cabot bought 500 Ambev shares in Q3 2026, an estimated $1.49K.
  • Ambev made up 0.01% of Moors & Cabot's portfolio in Q3 2026, its #775 holding.
  • Moors & Cabot first reported a position in Ambev in Q2 2020 and has held it in 26 quarters since.
  • Moors & Cabot's Ambev position peaked at $312K in Q2 2026.
  • 197 funds tracked by Wall St. Rank held Ambev as of Q3 2026.

Based on Moors & Cabot's 13F filing for Q3 2026, filed 6 Nov 2026.